Since the aberrant expression of the double homeobox 4 (DUX4) gene has been suggested as a predominant cause of FSHD pathogenesis [12,13,14], targeting DUX4 has great potential to provide a cure for the disease. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.